| Literature DB >> 28484893 |
Jing Wei1,2, Jing-Rui Chen1,2, Eva Maria Arriero Pais3, Tai-Yi Wang1,2, Lin Miao1,2, Lan Li1,2, Ling-Yan Li1,2, Feng Qiu1,2, Li-Min Hu1,2, Xiu-Mei Gao4,5, Guan-Wei Fan6,7,8.
Abstract
Recent studies suggest an anti-inflammatory activity of oxyresveratrol, a stilbene extracted from Cortex mori root used in traditional Chinese medicine that also presents estrogen-like activity. We herein tested the hypothesis that oxyreservatrol exerts an anti-inflammatory effect through its estrogenic-like function. In MCF-7 cells, oxyresveratrol significantly induced proliferation, which was accompanied with estrogen receptor (ER)-mediated transcriptional activation, increased estrogen-targeted gene expression (e.g., pS2, PGR, and CTSD), and increased ERα/β proteins. The estrogen-like effect of oxyresveratrol was reversed by the ER inhibitor ICI 182780. Strong ER-binding activities of oxyresveratrol were revealed by negative docking scores. The LPS-induced inflammatory response (e.g., upregulated IκB-α phosphorylation, NF-κB nuclear translocation, and cytokine messenger RNA expression) was significantly suppressed in an ER-dependent manner by oxyresveratrol in RAW264.7 cells. These results suggest that oxyresveratrol may function as an ER agonist and modulate NF-κB signaling.Entities:
Keywords: Cortex Mori; NF-κB signaling pathways; anti-inflammatory; estrogen; oxyresveratrol
Mesh:
Substances:
Year: 2017 PMID: 28484893 DOI: 10.1007/s10753-017-0572-y
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092